W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Home » Results:(Strona 2)

Opinion of the Transparency Council – lisinopril + amlodipine

10 May, 2023
więcej...

Opinion of the Transparency Council – candesartan + amlodipine

10 May, 2023
więcej...

Opinion of the Transparency Council – candesartan + hydrochlorothiazide

10 May, 2023
więcej...

Opinion of the Transparency Council – amlodipine + valsartan+ hydrochlorothiazide

10 May, 2023
więcej...

Opinion of the Transparency Council – amlodipine + valsartan

10 May, 2023
więcej...

Position of the Transparency Council – Welireg (belzutifan)

10 May, 2023
więcej...

Position of the Transparency Council – Tresiba (insulin degludec)

10 May, 2023
więcej...

Collegium AOTMiT – Cost Accounting Standard – statistics on trainings

16 December, 2022
więcej...

Opinion of the President – Health policy programme of the Municipality of Kleszczów for 2023-2025 in the scope of prevention of dental and oral diseases

10 January, 2023
więcej...

Opinion of the Transparency Council – program polityki zdrowotnej miasta Pszczyna dotyczący cukrzycy typu 2

22 February, 2023
więcej...

Opinion of the Transparency Council – health policy programme for the municipality of Pszczyna in the field of early detection of colorectal cancer

22 February, 2023
więcej...

Position of the Transparency Council – Update

22 February, 2023
więcej...

Position of the Transparency Council – Keytruda (pembrolizumab)

22 February, 2023
więcej...

Position of the Transparency Council – Glypvilo (vildagliptin)

22 February, 2023
więcej...

Position of the Transparency Council – Saphnelo (anifrolumab)

22 February, 2023
więcej...

Opinion of the Transparency Council – amendments to the prenatal testing programme

22 February, 2023
więcej...

Opinion of the Transparency Council – health policy programme for the of the Municipality of Miękinia on vaccination against meningococcus type B

22 February, 2023
więcej...

Opinion of the Transparency Council – health policy programme of the Opolskie Voivodeship to support the diagnosis and treatment of infertility

22 February, 2023
więcej...

Opinion of the Transparency Council – lenalidomide

22 February, 2023
więcej...

Position of the Transparency Council – Vimetso (vildagliptin + metformin hydrochloride)

22 February, 2023
więcej...

Opinion of the Transparency Council – health policy programme of the City of Tychy in the scope of infertility treatment with IVF technique

22 February, 2023
więcej...

Opinion of the Transparency Council – health policy programme of the Municipality of Sztutowo in the field of health needs and health status

22 February, 2023
więcej...

Position of the Transparency Council – Xiaflex/Xiapex (collagenase Clostridium histolyticum)

22 February, 2023
więcej...

Position of the Transparency Councii – Findarts Duo (dutasteride + tamsulosin hydrochloride)

22 February, 2023
więcej...
Home page
Telefon
Email